Cohort Study and Meta-Analysis: Long-term Antithrombotic Therapy and Risk of Intracranial Hemorrhage from Cerebral Cavernous Malformations

Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis – The Lancet Neurology (free)

Invited Commentary: Antithrombotics and bleeding risk: paradoxical findings (free)

Related Commentary on Twitter

Antithrombotic drugs might DECREASE the risk of bleeding from cavernomas! This reassuring finding in our https://t.co/CgTlSJxrek cohort study funded by @TheStrokeAssoc @The_MRC @CSO_Scotland needs to be tested in a RCT next… @CAUK1 @AngiomaAlliance https://t.co/w8Z4oH6Dvg pic.twitter.com/kyZAw9xXNQ

— Rustam Salman (@BleedingStroke) August 8, 2019